Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer

Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer

(2018) Yang Zhang et al.   CHEST

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

(2018) David A. Mahvi et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

(2016) Frank C. Detterbeck et al.   Journal of Thoracic Oncology

Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival

(2015) Hideki Ujiie et al.   JOURNAL OF CLINICAL ONCOLOGY

The 2015 World Health Organization Classification of Lung Tumors

(2015) William D. Travis et al.   Journal of Thoracic Oncology

Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival

(2014) Jung-Jyh Hung et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma

(2013) Jung-Jyh Hung et al.   ANNALS OF SURGERY

Prognostic Factors and the Significance of Treatment After Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer

(2013) Yoshihisa Shimada et al.   CHEST

Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer

(2013) I. H. Song et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

The Use and Interpretation of Competing Risks Regression Models

(2012) J. J. Dignam et al.   CLINICAL CANCER RESEARCH

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

(2012) Arne Warth et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma

(2012) Jie Gu et al.   JOURNAL OF SURGICAL ONCOLOGY

Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung Cancer

(2012) Jung-Jyh Hung et al.   Journal of Thoracic Oncology

A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma

(2012) Kyuichi Kadota et al.   MODERN PATHOLOGY

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

(2011) Prudence A. Russell et al.   Journal of Thoracic Oncology

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

(2010) Gabriel Sica et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Factors associated with recurrence in patients with curatively resected stage I–II lung cancer

(2010) Hyeon-Kyoung Koo et al.   LUNG CANCER

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis

(2010) J.-J. Hung et al.   THORAX

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence

(2009) J-J Hung et al.   THORAX

Postrecurrence survival in patients with stage I non-small cell lung cancer

(2008) Tatsuo Nakagawa et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer

(2008) Malcolm V. Brock et al.   NEW ENGLAND JOURNAL OF MEDICINE